Fig. 6: IL33 expression selectively maps to Sca1± thymic mesenchyme. | Nature Communications

Fig. 6: IL33 expression selectively maps to Sca1± thymic mesenchyme.

From: The alarmin IL33 orchestrates type 2 immune-mediated control of thymus regeneration

Fig. 6

a Representative FACs plots illustrating the proportion of IL33cit expressing CD45+ thymic cells and total CD45- thymic stromal cells (blue histogram). Red histograms represent florescence levels in control WT mice. b Quantitation of IL33cit expression in defined thymic stromal populations; cTEC (CD45-EpCAM-1UEA1Ly51+), mTEC (CD45-EpCAM-1UEA1+Ly51), mTEChi (CD45-EpCAM-1UEA1+Ly51MHCII+CD80+), mTEClo(CD45-EpCAM-1-UEA1+Ly51MHCII-CD80), Endothelium (TER119CD45EpCAM-1CD31+), Mesenchyme (TER119CD45EpCAM-1CD31Integrinα7), Pericytes (TER119CD45EpCAM-1CD31Integrinα7+), (where n = 7 animals for TEC subsets and n = 5 animals for all other subsets, obtained from 2 independent experiments). c Representative FACs plots showing Sca-1 expression in thymic mesenchyme, and IL33cit expression within Sca-1+ and Sca-1 subsets. Blue histograms are from IL33cit mice, red histograms from control WT mice. d Total thymus cellularity, Sca-1+ mesenchyme numbers/proportions in WT mice following SLI exposure at indicated time points (n = 6 animals obtained from 2 independent experiments) with statistical analysis from a one-way ANOVA comparing means of each group to D0 with Dunnett’s multiple comparisons. e Comparative analysis of TEC (blue line) and Sca-1+ mesenchyme (red line) recovery at indicated time points in WT mice (n = 6 animals obtained from 2 independent experiments). f FACs plots showing IL4Rα expression in Sca-1+ mesenchyme from WT (blue histogram) mice, where against Il4ra−/− mice (red histogram) were used for control staining levels. g Quantitation of Sca1+ mesenchyme in WT and Il4ra−/− mice at steady state (D0) (WT n = 5 and Il4ra−/− n = 6 animals obtained from 2 independent experiments), from a two-tailed unpaired Student’s t test. h Injection and irradiation regime of 5μg recombinant IL4-complexes/PBS into WT mice. Analysis of Sca-1+ mesenchyme was performed at day 7 and day 14 after injection regime, n = 6 minimum. i Numbers of Sca-1+ thymic mesenchyme cells at day 7 and day 14 post-SLI following PBS (D7 n = 6 and D14 n = 7 animals) or IL4c (D7 n = 7 and D14 n = 7 animals) injection, obtained from 2 independent experiments. Statistics from a two-tailed unpaired Student’s t test. All analysis was carried out across at least two independent experiments. All error bars show mean ± SEM.

Back to article page